Cargando…

Tinzaparin—a review of its molecular profile, pharmacology, special properties, and clinical uses

PURPOSE: Low molecular weight heparins (LMWHs) are a group of heterogenous moieties, long used in the prevention and treatment of thrombosis. They derive from heparin and since they are prepared by different methods of depolymerization, they differ in pharmacokinetic properties and anticoagulant pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amerali, Marina, Politou, Marianna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308487/ https://www.ncbi.nlm.nih.gov/pubmed/35871241 http://dx.doi.org/10.1007/s00228-022-03365-4

Ejemplares similares

The Role of Tinzaparin in Oncology
por: Dimakakos, Evangelos P., et al.
Publicado: (2017)

Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review
por: Vathiotis, I. A., et al.
Publicado: (2021)

Tinzaparin and other low-molecular-weight heparins: what is the evidence for differential dependence on renal clearance?
por: Johansen, Kristian B, et al.
Publicado: (2013)

Cancer-Associated Thrombosis: Not All Low-Molecular-Weight Heparins Are the Same, Focus on Tinzaparin, A Narrative Review
por: Fioretti, Agnese Maria, et al.
Publicado: (2022)

Tinzaparin vs. Nadroparin Safety and Efficacy in Neurosurgery
por: Wilhelmy, Florian, et al.
Publicado: (2021)

Tinzaparin for Long-Term Treatment of Venous Thromboembolism in Patients With Cancer: A Systematic Review and Meta-Analysis
por: Martínez-Zapata, M. José, et al.
Publicado: (2017)

Heparin/tinzaparin-sodium: Lack of efficacy: 3 case reports
Publicado: (2020)

Tinzaparin-sodium: Bleeding and deep venous thrombosis: case report
Publicado: (2022)

Weight-adjusted dosing of tinzaparin for thromboprophylaxis in obese medical patients
por: Pfrepper, Christian, et al.
Publicado: (2023)

Tinzaparin Provides Lower Lipid Profiles in Maintenance Hemodialysis Patients: A Cross-Sectional Observational Study
por: Tsai, Ming-Hsien, et al.
Publicado: (2014)

Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis
por: Mahmood, Dana, et al.
Publicado: (2010)

Extended-Duration Treatment of Superficial Vein Thrombosis of the Lower Limbs with Tinzaparin
por: Nikolakopoulos, Konstantinos M., et al.
Publicado: (2018)

Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications
por: Helfer, Hélène, et al.
Publicado: (2019)

Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study
por: Akinosoglou, Karolina, et al.
Publicado: (2022)

Prophylaxis of cancer-associated venous thromboembolism with low-molecular-weight heparin-tinzaparin: Real world evidence
por: Christopoulou, Athina, et al.
Publicado: (2022)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
por: Trujillo‐Santos, Javier, et al.
Publicado: (2022)

Single-Bolus Tinzaparin Anticoagulation in Extended Hemodialysis Session: A Feasibility Study
por: Harvey, Benoît, et al.
Publicado: (2023)

Spontaneous gall bladder haemorrhage in a renal dialysis patient following haemodialysis with tinzaparin
por: Borman, Natalie, et al.
Publicado: (2010)

The Low Molecular Weight Heparin Tinzaparin Attenuates Platelet Activation in Terms of Metastatic Niche Formation by Coagulation-Dependent and Independent Pathways
por: Gockel, Lukas Maria, et al.
Publicado: (2018)

Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer
por: Sarantis, Panagiotis, et al.
Publicado: (2021)

Clinical and pharmacological properties of incobotulinumtoxinA and its use in neurological disorders
por: Jost, Wolfgang H, et al.
Publicado: (2015)

The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers—Preclinical In Vivo Evaluation in Xenograft Tumor Models
por: Mueller, Thomas, et al.
Publicado: (2017)

The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study
por: Karamouzis, Michalis V., et al.
Publicado: (2021)

TILE pilot trial study protocol: Tinzaparin Lead-in to Prevent the Post-Thrombotic syndrome study protocol
por: Makedonov, Ilia, et al.
Publicado: (2023)

The Alkaloid Alstonine: A Review of Its Pharmacological Properties
por: Elisabetsky, E., et al.
Publicado: (2006)

Thuja occidentalis (Arbor vitae): A Review of its Pharmaceutical, Pharmacological and Clinical Properties
por: Naser, Belal, et al.
Publicado: (2005)

Ropivacaine: A review of its pharmacology and clinical use
por: Kuthiala, Gaurav, et al.
Publicado: (2011)

CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients
por: Lee, Agnes YY, et al.
Publicado: (2013)

Xanthorrhizol: a review of its pharmacological activities and anticancer properties
por: Oon, Seok Fang, et al.
Publicado: (2015)

Aripiprazole: from pharmacological profile to clinical use
por: Di Sciascio, Guido, et al.
Publicado: (2015)

Effects of Antithrombotic Drugs Fondaparinux and Tinzaparin on In Vitro Proliferation and Osteogenic and Chondrogenic Differentiation of Bone-Derived Mesenchymal Stem Cells
por: Papathanasopoulos, Argiris, et al.
Publicado: (2011)

Risk of recurrent thromboembolic events according to treatment duration in patients with superficial vein thrombosis treated with intermediate dose of tinzaparin
por: Karathanos, Christos, et al.
Publicado: (2022)

Review on the Pharmacological Properties of Phillyrin
por: Zhou, Chenyu, et al.
Publicado: (2022)

Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic Properties
por: Jorgensen, Sarah C. J., et al.
Publicado: (2018)

Gabapentin: An update of its pharmacological properties and therapeutic use in epilepsy
por: Honarmand, Azim, et al.
Publicado: (2011)

Ziziphus nummularia: A Comprehensive Review of Its Phytochemical Constituents and Pharmacological Properties
por: Mesmar, Joelle, et al.
Publicado: (2022)

Unravelling the pharmacological properties of cryptolepine and its derivatives: a mini-review insight
por: Tudu, Champa Keeya, et al.
Publicado: (2022)

Engineering of Nisin as a Means for Improvement of Its Pharmacological Properties: A Review
por: Musiejuk, Mateusz, et al.
Publicado: (2023)

Smilax glabra Roxb.: A Review of Its Traditional Usages, Phytochemical Constituents, Pharmacological Properties, and Clinical Applications
por: Wu, Hao, et al.
Publicado: (2022)

Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection
por: Dickinson, Robert, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_8jamijburtt4ee0gl8ahiq50pb